Why Not Both? Dual Biologics for RA and PsA : comparemela.co

Previous clinical trials of dual biologic therapies have raised safety issues, but more recent, promising findings from clinical trials and case series have renewed interest in the treatment approach.

Related Keywords

London , City Of , United Kingdom , Erlangen , Bayern , Germany , Canada , Rochester , New York , United States , University Of Rochester , France , Melek Yal , Brian Feagan , Christopher Ritchlin , University Clinic Erlangen , Clinical Immunology Research Unit , American College Of Rheumatology , Friedrich Alexander University Erlangen , Medscape Medical , Multiple Mechanisms , Friedrich Alexander University Erlangen Nuremberg , Joint Bone , American College , Right Patients ,